Pmv Pharmaceuticals Inc (PMVP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 361,422 | 73,278 | 0 | N/A | N/A |
| Marketable Securities | 0 | 28,208 | 0 | N/A | N/A |
| TOTAL | $364,761 | $102,093 | $0 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 569 | 739 | 0 | N/A | N/A |
| Other Non-Current Assets | 201 | 201 | 0 | 0 | 0 |
| TOTAL | $770 | $940 | $N/A | $N/A | $N/A |
| Total Assets | $365,531 | $103,033 | $0 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,607 | 2,837 | 0 | 0 | 0 |
| Accrued Expenses | 4,803 | 1,686 | 0 | N/A | N/A |
| TOTAL | $6,410 | $4,523 | $0 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 168,984 | 0 | 0 | 0 |
| TOTAL | $N/A | $168,984 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,410 | $173,507 | $0 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,783 | N/A | N/A | N/A | N/A |
| Retained earnings | -109,880 | -75,440 | 0 | N/A | N/A |
| Other shareholders' equity | 0 | -3 | 0 | 0 | 0 |
| TOTAL | $359,121 | $-70,474 | $0 | $N/A | $N/A |
| Total Liabilities And Equity | $365,531 | $103,033 | $0 | $0 | $0 |